Open AccessPatient-tailored FOLFIRINOX as first line treatment of patients with advanced pancreatic adenocarcinoma
Author(s) -
Ayhan Ulusakarya,
Nahla Teyar,
Abdoulaye Karaboué,
Mazen Haydar,
Sarra Krimi,
Pamela Biondani,
Yusuf Yasin Gümüş,
Amale Chebib,
Wathek Almohamad,
JeanFrançois Morère
Publication year - 2019
Publication title -
medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.59
H-Index - 148
eISSN - 1536-5964
pISSN - 0025-7974
DOI - 10.1097/md.0000000000015341
Subject(s) - folfirinox , medicine , irinotecan , oxaliplatin , gemcitabine , pancreatic cancer , gastroenterology , surgery , clinical endpoint , chemotherapy , cancer , clinical trial , colorectal cancer